Targeting Intestinal Inflammation With CD98 siRNA/PEI–loaded Nanoparticles FREE
Hamed Laroui, Duke Geem, Bo Xiao, Emilie Viennois, Poonam Rakhya, Timothy Denning and Didier Merlin
Mol Ther 22: 69-80; advance online publication, November 26, 2013; doi:10.1038/mt.2013.214
In Vitro and In Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of Glaucoma FREE
Tamara Martínez, Maria Victoria González, Ingo Roehl, Natalia Wright, Covadonga Pañeda and Ana Isabel Jiménez
Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma MTOpen
Whay-Kuang Chia, Marissa Teo, Who-Whong Wang,
Bernett Lee, Soo-Fan Ang, Wai-Meng Tai, Chit-Lai Chee, Joanna Ng,
Rebecca Kan, Wan-Teck Lim, Sze-Huey Tan, Whee-Sze Ong, Yin-Bun Cheung,
Eng-Huat Tan, John E Connolly, Stephen Gottschalk and Han-Chong Toh
Mol Ther 22: 132-139; advance online publication, December 3, 2013; doi:10.1038/mt.2013.242
Phase I Clinical Trial of SYL040012, a Small Interfering RNA Targeting β-Adrenergic Receptor 2, for Lowering Intraocular Pressure FREE
Javier Moreno-Montañés, Belén Sádaba, Verónica Ruz,
Almudena Gómez-Guiu, Javier Zarranz, María Victoria González,
Covadonga Pañeda and Ana Isabel Jimenez
Mol Ther 22: 226-232; advance online publication, October 15, 2013; doi:10.1038/mt.2013.217
No comments:
Post a Comment